Health Canada licenses MAMMOMAT Revelation
July 10, 2019
OTTAWA – Health Canada has licensed the MAMMOMAT Revelation, a premium mammography platform from Siemens Healthineers with the new InSpect integrated specimen imaging tool and the new HD Breast Biopsy solution for one-click targeting of suspicious areas. These and other features are designed to expand precision medicine and improve the patient experience.
MAMMOMAT Revelation’s InSpect integrated specimen imaging tool permits imaging and real-time review of biopsy samples at the workstation. This tool improves biopsy workflow, shortens compression time, and reduces patient discomfort.
HD Breast Tomosynthesis offers the widest image acquisition angle available at 50 degrees. The wide angle delivers the industry’s highest depth resolution for better separation of overlapping breast tissue, providing high-quality 3D images for improved diagnostic confidence and earlier lesion detection. This technology is the basis for MAMMOMAT Revelation’s HD Breast Biopsy solution, which enables one-click targeting of suspicious areas with a +/- 1mm accuracy, the company said.
For women aged 40-74 years, 43% have dense breasts, complicating efforts to identify breast lesions. Typically, the radiologist assesses breast density visually after the patient has left the facility. MAMMOMAT Revelation is the first platform to offer automated breast density measurement during the mammogram for immediate, personalized risk stratification, and more personalized care.
MAMMOMAT Revelation’s Personalized Soft Compression adjusts the level of breast compression automatically to suit each patient’s anatomy. Coupled with ergonomic SoftComp Paddles, Personalized Soft Compression enables improved breast positioning, more consistent image quality, and less discomfort and anxiety.
And for inconclusive cases, MAMMOMAT Revelation offers titanium contrast-enhanced mammography as a cost-effective alternative to magnetic resonance imaging (MRI), reducing scheduling conflicts and reassuring the patient.
“MAMMOMAT Revelation provides automated measurements of breast density at the point of examination,” said Peter Vidic, business manager of X-ray products at Siemens Healthineers Canada. “This allows for instant risk stratification – before the patient leaves.”
For further information on the MAMMOMAT Revelation, please see https://www.siemens-healthineers.com/en-ca/mammography/digital-mammography/mammomat-revelation
About Siemens Healthineers
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide. Further information is available at www.siemens-healthineers.com.